| Source: |
| Type: |
| custom |
| 6688- | DFC, | New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells |
| - | in-vivo, | lymphoma, | U937 |
| 6663- | DFE, | Nutraceuticals of Phoenix dactylifera L.: Physicochemistry, Nutritional Value and Therapeutic Potential |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6666- | DFE, | The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation |
| - | in-vitro, | Colon, | Caco-2 |
| 2170- | dietMet, | Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population |
| - | Study, | Var, | NA |
| 5193- | dietMet, | Rad, | A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy |
| - | Trial, | Var, | NA |
| 5190- | dietMet, | Methionine restriction activates the integrated stress response in triple-negative breast cancer cells by a GCN2- and PERK-independent mechanism |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 5065- | dietSTF, | dietFMD, | Nutrition, GH/IGF-I Signaling, and Cancer |
| - | Review, | Var, | NA |
| 6267- | DL, | Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis |
| - | Review, | BC, | NA |
| 6268- | DL, | Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2) |
| - | in-vitro, | Liver, | HepG2 |
| 6272- | DL, | Anti‐leukemic and anti‐angiogenic effects of d‐Limonene on K562‐implanted C57BL/6 mice and the chick chorioallantoic membrane model |
| - | vitro+vivo, | CLL, | NA |
| 6288- | DL, | From Citrus to Clinic: Limonene’s Journey Through Preclinical Research, Clinical Trials, and Formulation Innovations |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6284- | DL, | Chemoprevention and therapy of cancer by d-limonene |
| - | in-vivo, | Var, | NA |
| 6344- | DRE, | Dandelion: Purported Benefits, Side Effects & More |
| - | Review, | Var, | NA |
| 6346- | DRE, | Unusual Response of Acute Monocytic Leukemia to Dandelion Root Extract |
| - | Case Report, | AML, | NA |
| 6349- | DRE, | Dandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitis |
| - | vitro+vivo, | Nor, | NCM460 |
| 6352- | DRE, | Investigation of the Anti-Lung Cancer Mechanisms of Taraxacum officinale Based on Network Pharmacology and Multidimensional Experimental Validation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | L929 |
| 6603- | Ech, | doxoR, | The effect of Echinacea purpurea on the pharmacokinetics of docetaxel |
| - | Trial, | Var, | NA |
| 6620- | Ech, | Echinacea purpurea diminishes neovascular reaction induced in mice skin by human cancer cells and stimulates non-specific cellular immunity in humans |
| - | in-vivo, | Var, | NA |
| 6617- | Ech, | Echinacea Angustifolia DC Extract Induces Apoptosis and Cell Cycle Arrest and Synergizes with Paclitaxel in the MDA-MB-231 and MCF-7 Human Breast Cancer Cell Lines |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
| 671- | EGCG, | The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer |
| 664- | EGCG, | AgNPs, | Epigallocatechin-3-gallate-capped Ag nanoparticles: preparation and characterization |
| - | Analysis, | NA, | NA |
| 678- | EGCG, | Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells |
| - | Trial, | NA, | NA |
| 2561- | EGCG, | ASA, | Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment |
| - | ex-vivo, | Nor, | NA |
| 3226- | EGCG, | Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells |
| - | in-vitro, | Nor, | NA |
| 3222- | EGCG, | Epigallocatechin gallate and mitochondria—A story of life and death |
| - | Review, | Nor, | NA |
| 3201- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | NA, | NA |
| 6110- | EP, | Leukemic cell intracellular responses to nanosecond electric fields |
| - | in-vitro, | AML, | NA |
| 5489- | EP, | Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation |
| - | in-vitro, | Colon, | NA |
| 5491- | EP, | Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors |
| - | in-vivo, | Melanoma, | B16-F10 |
| 5493- | EP, | Schottky nanodiodes array enabled triboelectric nanosecond pulse generator for ultralow-cost tumor therapy |
| - | Review, | Var, | NA |
| 5494- | EP, | An Overview of Subnanosecond Pulsed Electric Field Biological Effects: Toward Contactless Technologies for Cancer Treatment |
| - | Review, | Var, | NA |
| 6575- | EU, | Eurycomanone from Eurycoma longifolia Jack upregulates neurotrophin-3 gene expression in retinal Müller cells in vitro |
| - | in-vivo, | Nor, | NA |
| 6383- | Eug, | In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3) |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6378- | Eug, | Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimer's Disease, Depression, and Parkinson's Disease |
| - | Review, | AD, | NA |
| 6377- | Eug, | Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4138- | Ex, | Relationship Between Exercise and Alzheimer’s Disease: A Narrative Literature Review |
| - | Review, | AD, | NA |
| 4141- | Ex, | Effects of exercise on brain-derived neurotrophic factor in Alzheimer's disease models: A systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 4143- | Ex, | Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 2174- | FA, | VitB12, |
| - | Analysis, | Var, | NA |
| 4073- | FA, | The importance of folic acid deficiency in the pathogenesis of vascular, mixed and Alzheimer's disease dementia |
| - | Study, | AD, | NA |
| 4069- | FA, | Folate, folic acid and 5-methyltetrahydrofolate are not the same thing |
| - | Review, | AD, | NA |
| 4076- | FA, | VitE, | VitB6, | Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging |
| - | Study, | AD, | NA |
| 4075- | FA, | Folic acid, ageing, depression, and dementia |
| - | Review, | AD, | NA |
| 4074- | FA, | VitB12, | Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study |
| - | Trial, | AD, | NA |
| 3716- | FA, | Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells |
| - | in-vitro, | IBD, | NA | - | in-vivo, | NA, | NA |
| 1915- | Fer, | Vascular Imaging With Ferumoxytol as a Contrast Agent |
| - | Analysis, | Var, | NA |
| 2859- | FIS, | The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways |
| - | in-vitro, | Liver, | HepG2 | - | NA, | Colon, | Caco-2 |
| 4108- | FLS, | Improvement of olfactory function in AD mice mediated by immune responses under 40 Hz light flickering |
| - | in-vivo, | AD, | NA |
| 4025- | FulvicA, | Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:767 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid